HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Health (OTC Drugs)

Set Alert for Health (OTC Drugs)

Regulation/Legislation Explore this Topic

Set Alert for Regulation and Legislation {Health}

Latest From Regulation, Legislation & Health

Restoring FTC Monetary Relief Authority: For Commission Members, Not One Size Fits All

House already passed legislation to amend Sec. 13(b) of FTC regulations and make explicit its authority to obtain injunctive and equitable relief in court, but differences in Democrat and Republican commission appointees' views on the authority was a key topic of discussion during a recent Energy and Commerce hearing.

Ad Complaints Consumer

US Firm's Supplement Claims For Hangover Relief Watered Down In Industry Self-Regulation Review

More Labs’ online claims might not be distilled satisfactorily for FDA’s taste for dietary supplement claims for hangover help agency made known a year ago. Firm will narrow claim suggesting its products could broadly relieve hangover symptoms.

Ad Complaints Dietary Supplements

Herbal Sprays, Nasal Swabs Latest Additions On List Of Fraudulent COVID Cures Offered In US

“Germaphobe’s Delight Spray” was “re-vamped … to better meet the challenges of COVID-19,” Fopo Jordan’s Crossing Herbal claimed. Halodine LLC claimed its nasal sanitizer “kills SARS-CoV-2 (the virus that causes COVID-19) in less than 15 seconds.”

Dietary Supplements FDA

US FDA Won't Budge On Nitrosamines Compliance Despite Complaints Of Possible Drug Shortages

Industry requests for deadline extensions, short-duration adjustments and other accommodations go nowhere as FDA expresses concerns about nitrosamines’ mutagenic potency.

FDA Ingredients

Five Must-Know Things About The UK’s Digital Self-Care Revolution

HBW Insight looks back at PAGB's Digital Week to extract the five must-know things for the OTC industry.

United Kingdom Health

Switzerland Reclassifies Rx Drugs For Migraine And Pain

Switzerland has added treatments for migraine and acute pain to the list of Rx drugs permitted for sale without prescription in pharmacy.

Switzerland Regulation
See All

Business Explore this Topic

Set Alert for Business {Health}

Latest From Deals & Health

Bausch Health Has Full Plate While Trimming Debt, Setting Table For Bausch + Lomb Separation

Bausch Health says it’s continuing a recovery from the disaster previous management left, when the firm operated as Valeant Pharmaceuticals, even though it reported a $595m net loss for Q2. “We've been trying to solve this debt issue for the company,” says CEO Joseph Papa.

Business Strategies Consumer

Stada To Market 50 Sanofi Brands Across Europe

Germany's Stada is strengthening its portfolio by taking over distribution of 50 well-established Sanofi Consumer Healthcare brands marketed across Europe.

Distribution Deals

Vision Healthcare Hires Perrigo Execs And Acquires Spanish VMS Player

Vision Healthcare has hired Perrigo's Geert Cools and Joost Hunfeld as CEO and chief growth officer respectively, while at the same time securing the acquisition of Spanish VMS player N2.

Appointments Deals
See All

Latest From Business Strategies & Health

Bausch Health Has Full Plate While Trimming Debt, Setting Table For Bausch + Lomb Separation

Bausch Health says it’s continuing a recovery from the disaster previous management left, when the firm operated as Valeant Pharmaceuticals, even though it reported a $595m net loss for Q2. “We've been trying to solve this debt issue for the company,” says CEO Joseph Papa.

Business Strategies Consumer

Church & Dwight Cuts Outlook Due To Rising Costs, Adds Suppliers To Strengthen ‘Weak Links’

“We expect higher input costs and transportation costs to remain elevated for the rest of the year,” says CEO Matthew Farrell. Firms lowers full-year outlook for net sales growth from previous range of 5% to 6% to around 5%.

Dietary Supplements Sales & Earnings

Final Quarter Of P&G CEO Taylor’s Tenure Could Become Stormy With Headwinds From Rising Costs

P&G’s health care sector’s net sales grew 18% in its latest quarter. Continued growth across its sectors is critical in the face of expected $1.8bn in headwinds from commodity and freight costs in its FY2022.

Business Strategies Sales & Earnings
See All

Latest From Sales & Earnings & Health

Church & Dwight Cuts Outlook Due To Rising Costs, Adds Suppliers To Strengthen ‘Weak Links’

“We expect higher input costs and transportation costs to remain elevated for the rest of the year,” says CEO Matthew Farrell. Firms lowers full-year outlook for net sales growth from previous range of 5% to 6% to around 5%.

Dietary Supplements Sales & Earnings

Euro Results Round-Up: Alliance Pharma, Boiron And Ipsen

Round-up of Q2 and H1 financial results from three Europe-based consumer health companies: Alliance Pharma, Ipsen and Boiron.

Sales & Earnings OTC Drugs

Final Quarter Of P&G CEO Taylor’s Tenure Could Become Stormy With Headwinds From Rising Costs

P&G’s health care sector’s net sales grew 18% in its latest quarter. Continued growth across its sectors is critical in the face of expected $1.8bn in headwinds from commodity and freight costs in its FY2022.

Business Strategies Sales & Earnings
See All

Latest From Legal Issues & Health

Alleged ‘Pink Tax’ Class Actions Against OTC Personal-Care Brands Moving Through Federal Courts

Walgreen Co. seeks to dismiss allegations in California’s Northern District that it unlawfully charges more for its OTC Hair Regrowth Treatment for women compared with a “functionally equivalent” offering for men. The suit follows “pink tax” litigation concerning Dove antiperspirants that defendants dismissed in July 2020, a decision affirmed by the Eighth Circuit in May.

United States Legal Issues

Second-Quarter Consumer Health Results Bring J&J Relief From Year-Ago Sales Plummet

In first of what could be similar April-June earnings results from major consumer health firms, J&J reports 9.2% operational growth to $3.74bn in sales. Worldwide consumer health chief Thibaut Mongon touts segment’s results and outlook but says similar growth in second half isn’t assured.

Coronavirus COVID-19 OTC Drugs

House Bill Restoring FTC Monetary Relief Tool Stretches ‘Look Back’ Authority From 3 To 10 Years

Limiting FTC authority to enforcement started after legislation passes rather than all pending complaints as House bill allows could be divisive. But consumer health marketers question number of years before a complaint is filed agency can allege a business used false and misleading advertising under legislation the House passed.

Ad Complaints Enforcement
See All

Marketing Explore this Topic

Set Alert for Marketing {Health}

Latest From Launches & Health

Health And Wellness Weekly Trademark Review 27 July, 2021

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Dietary Supplements OTC Drugs

Health And Wellness Weekly Trademark Review 20 July, 2021

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Dietary Supplements OTC Drugs

Rosesta Medical Launches ‘Sperm Friendly’ Conception Gel Across Europe

Dutch fertility specialist Rosesta Medical is launching its new conception gel across Europe under its established FERTI·LILY brand.

Netherlands Health
See All

Latest From Ad Campaigns & Health

Five Must-Know Things About The UK’s Digital Self-Care Revolution

HBW Insight looks back at PAGB's Digital Week to extract the five must-know things for the OTC industry.

United Kingdom Health

UK’s Ascension Teams Up With Women’s Football Star To Raise Awareness Of Osteoarthritis

Women's football star and TV personality Alex Scott MBE becomes brand ambassador for Ascension Healthcare's UK pain relief brand FlexiSEQ.

United Kingdom Health

With Spring's Arrival, OTC Allergy Ad Campaigns Bloom In US For Claritin, Flonase

Bayer launches multi-year campaign “Outsideologist Project” for Claritin to offer parents fun ways to get their children outside. GSK’s “Change the Game” campaign for Flonase as official allergy relief partner of MLB has new spokesman.

Ad Campaigns OTC Drugs
See All

Latest From Ad Complaints & Health

Restoring FTC Monetary Relief Authority: For Commission Members, Not One Size Fits All

House already passed legislation to amend Sec. 13(b) of FTC regulations and make explicit its authority to obtain injunctive and equitable relief in court, but differences in Democrat and Republican commission appointees' views on the authority was a key topic of discussion during a recent Energy and Commerce hearing.

Ad Complaints Consumer

US Firm's Supplement Claims For Hangover Relief Watered Down In Industry Self-Regulation Review

More Labs’ online claims might not be distilled satisfactorily for FDA’s taste for dietary supplement claims for hangover help agency made known a year ago. Firm will narrow claim suggesting its products could broadly relieve hangover symptoms.

Ad Complaints Dietary Supplements

House Bill Restoring FTC Monetary Relief Tool Stretches ‘Look Back’ Authority From 3 To 10 Years

Limiting FTC authority to enforcement started after legislation passes rather than all pending complaints as House bill allows could be divisive. But consumer health marketers question number of years before a complaint is filed agency can allege a business used false and misleading advertising under legislation the House passed.

Ad Complaints Enforcement
See All
UsernamePublicRestriction

Register